Research-Grade Growth Hormone Analysis
Norditropin Simplexx 10mg (30IU) is a pharmaceutical-grade recombinant human growth hormone manufactured by Novo Nordisk, representing one of the most sophisticated protein therapeutics available for laboratory investigation. This lyophilised preparation contains 30 international units of somatropin, providing researchers at Stroid UK Shop with authentic pharmaceutical material for studying growth factor biology and cellular regeneration mechanisms. The compound’s molecular structure identical to endogenous human growth hormone enables precise investigation of somatotropic pathways in controlled laboratory environments.
Laboratory Investigation Applications
Research scientists utilise this growth hormone preparation to examine cellular proliferation dynamics, protein synthesis regulation, and metabolic pathway modulation in vitro. Studies focus on investigating how growth hormone influences cellular energy metabolism, examining its effects on carbohydrate and lipid metabolism pathways. Researchers analyse the compound’s interaction with growth hormone receptors, studying signal transduction cascades and downstream cellular responses. Comparative studies alongside other growth hormone preparations enable comprehensive analysis of bioactivity variations. Investigations extend to examining the compound’s stability characteristics and reconstitution properties for laboratory protocols. Advanced research applications include studying the molecule’s interaction with binding proteins and investigating its role in cellular regeneration processes. Some laboratories incorporate this material into broader research programs examining endocrine system function, often comparing results with studies involving selective androgen receptor modulators or research peptides for comprehensive metabolic pathway analysis.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Substance | Somatropin (recombinant human growth hormone) |
| Concentration | 10mg (30 IU) |
| Manufacturer | Novo Nordisk |
| Molecular Formula | C990H1528N262O300S7 |
| Molecular Weight | 22,124 Da |
| Storage Conditions | 2-8°C refrigerated |
| Form | Lyophilised powder for reconstitution |
Research Use Compliance
This Norditropin Simplexx preparation is supplied exclusively for in-vitro laboratory research applications. Not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate institutional approvals and safety protocols are established before conducting investigations with this material.
